Cardiovascular

Chronic Stable Angina: Should ESC Guidelines on Clopidogrel as Pre-Treatment to Planned Coronary Angiography be Changed?

Petr Widimsky
Petr Widimsky
Eckhart Fleck
Eckhart Fleck

REFERENCE: Hot Line II Monday 3rd Sept, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
PETR WIDIMSKY, Charles University, Prague
COMMENT: ECKART FLECK, Deutsches Herzzentrum Berlin

The ESC guideline suggesting all patients with chronic stable angina having coronary angiography should have clopidogrel pre-treatment is now being questioned following findings of the PRAGUE-8 Study, which randomized patients to receive the anti-platelet agent either non selectively before angiography, or selectively after angiography in those considered to need PCI. The PRAGUE investigators concluded that the ESC guideline was unjustified for the treatment of elective angiography in chronic stable angina, and that the previous practice of selective administration of clopidogrel should be resumed. Nicola Solomon talked with Petr Widimsky at the ESC Congress in Vienna. Derek Thorne heard comments on the findings from Eckart Fleck.

Similar Interviews

  • Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?
  • HARVEY WHITE, Auckland City Hospital REFERENCE: ACC 2007 & N Engl J Med 356: March 2007 The finding from the COURAGE trial:

  • COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help - ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
  • STEVEN NISSEN, Cleveland Clinic, OH REFERENCE: N Engl J Med 2007 356 Reporting from: American College of Cardiolgy New Orleans Two big studies

  • Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
  • Post a comment

    Subscribe to Audio Medica Podcast